CD1A/B Rabbit Polyclonal Antibody

CD1A/B Rabbit Polyclonal Antibody

To Order Contact Us Below:

    CD1A/B Polyclonal Antibody

    ES8784-50ul 50ul
    EUR 248.4
    Description: A Rabbit Polyclonal antibody against CD1A/B from Human. This antibody is tested and validated for IHC, WB, ELISA

    Anti-CD1A/B antibody

    STJ98989 200 µl
    EUR 236.4
    Description: Rabbit polyclonal to CD1A/B.

    CD1A Rabbit pAb

    A5722-100ul 100 ul
    EUR 369.6

    CD1A Rabbit pAb

    A5722-200ul 200 ul
    EUR 550.8

    CD1A Rabbit pAb

    A5722-20ul 20 ul
    EUR 219.6

    CD1A Rabbit pAb

    A5722-50ul 50 ul
    EUR 267.6

    CD1A antibody

    70R-16257 50 ul
    EUR 522
    Description: Rabbit polyclonal CD1A antibody

    CD1a Antibody

    49610-100ul 100ul
    EUR 399.6

    CD1a Antibody

    49610-50ul 50ul
    EUR 286.8

    CD1A Antibody

    32993-100ul 100ul
    EUR 302.4

    CD1a antibody

    10R-6325 100 ug
    EUR 249.6
    Description: Mouse monoclonal CD1a antibody

    CD1A antibody

    10R-7787 500 ug
    EUR 678
    Description: Mouse monoclonal CD1A antibody

    CD1A antibody

    10R-10717 100 ug
    EUR 418.8
    Description: Mouse monoclonal CD1A antibody

    CD1A antibody

    10R-10739 100 ug
    EUR 418.8
    Description: Mouse monoclonal CD1A antibody

    CD1A Antibody

    BF0122 200ul
    EUR 540

    CD1A Antibody

    1-CSB-PA789186
    • EUR 380.40
    • EUR 292.80
    • 100ul
    • 50ul
    Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

    CD1a Antibody

    DF13391 100ul
    EUR 420

    CD1A Antibody

    1-CSB-PA004889ESR1HU
    • EUR 266.40
    • EUR 402.00
    • 100ul
    • 50ul
    Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

    CD1A Antibody

    1-CSB-PA004889ESR2HU
    • EUR 266.40
    • EUR 402.00
    • 100ul
    • 50ul
    Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200

    CD1A Antibody

    1-CSB-PA004889GA01HU
    • EUR 716.40
    • EUR 399.60
    • 150ul
    • 50ul
    Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF

    CD1a Antibody

    R30975 100 ug
    EUR 419

    CD1a Antibody

    F53637-0.1ML 0.1 ml
    EUR 379

    CD1a Antibody

    F43045-0.08ML 0.08 ml
    EUR 165

    CD1a Antibody

    F43045-0.4ML 0.4 ml
    EUR 379

    CD1a Antibody

    V8193-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V8193-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V8193SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2948-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2948-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2948SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2949-100UG 100 ug
    EUR 499
    Description: CD1a is an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. [UniProt]

    CD1a Antibody

    V2949-20UG 20 ug
    EUR 219
    Description: CD1a is an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. [UniProt]

    CD1a Antibody

    V2949SAF-100UG 100 ug
    EUR 499
    Description: CD1a is an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. [UniProt]

    CD1a Antibody

    V3253-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V3253-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V3253SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V3541-100UG 100 ug
    EUR 499
    Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V3541-20UG 20 ug
    EUR 219
    Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V3541IHC-7ML 7 ml
    EUR 499
    Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V3541SAF-100UG 100 ug
    EUR 499
    Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7012-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7012-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7012SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7231-100UG 100 ug
    EUR 499
    Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin.

    CD1a Antibody

    V7231-20UG 20 ug
    EUR 219
    Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin.

    CD1a Antibody

    V7231IHC-7ML 7 ml
    EUR 499
    Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin.

    CD1a Antibody

    V7231SAF-100UG 100 ug
    EUR 499
    Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin.

    CD1a Antibody

    V7376-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7376-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7376IHC-7ML 7 ml
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V7376SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2025-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2025-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2025IHC-7ML 7 ml
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2025SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2026-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2026-20UG 20 ug
    EUR 219
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2026IHC-7ML 7 ml
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a Antibody

    V2026SAF-100UG 100 ug
    EUR 499
    Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).

    CD1a

    1AA-100T 100 test
    EUR 418.8

    CD1a

    1AB-01MG 100 test
    EUR 340.8

    CD1a

    1ACFB-100T 100 test
    EUR 465.6

    CD1a

    1AF-100T 100 test
    EUR 356.4

    CD1a

    1APE-100T 100 test
    EUR 418.8

    CD1a

    1APPC5.5-100T 100 test
    EUR 434.4

    CD1a

    1APU-01MG 0,1 mg
    EUR 262.8

    CD1A

    PR27288 5 ug
    EUR 381.6

    Polyclonal CD1A antibody - C-terminal region

    APR01536G 0.05mg
    EUR 633.6
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD1A - C-terminal region. This antibody is tested and proven to work in the following applications:

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx159382
    • EUR 326.40
    • EUR 276.00
    • 100 ug
    • 50 ug

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx139080-01mg 0.1 mg
    EUR 444

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx141314
    • EUR 444.00
    • EUR 727.20
    • EUR 360.00
    • 100 ul
    • 200 ul
    • 50 ul

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx146226-100ug 100 ug
    EUR 469.2

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx004375
    • EUR 493.20
    • EUR 710.40
    • EUR 218.40
    • EUR 376.80
    • 100 ul
    • 200 ul
    • 20 ul
    • 50 ul

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx111464
    • EUR 878.40
    • EUR 477.60
    • 150 ul
    • 50 ul

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx010518-100ul 100 ul
    EUR 493.2

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx015794-100ul 100 ul
    EUR 493.2

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx027451-400ul 400 ul
    EUR 627.6

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx027451-80l 80 µl
    EUR 343.2

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx200001-100ug 100 ug
    EUR 393.6

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx320639
    • EUR 360.00
    • EUR 292.80
    • 100 ul
    • 50 ul

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx322311
    • EUR 360.00
    • EUR 292.80
    • 100 ul
    • 50 ul

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx415367-01mg 0.1 mg
    EUR 543.6

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx415541-02mg 0.2 mg
    EUR 678

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx415548-01mg 0.1 mg
    EUR 526.8

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx231434-100ug 100 ug
    EUR 610.8

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    abx231435-100ug 100 ug
    EUR 577.2

    T-cell Surface Glycoprotein CD1a (CD1A) Antibody

    20-abx211317
    • EUR 493.20
    • EUR 360.00
    • 100 ul
    • 50 ul

    CD1a antibody (FITC)

    61R-1030 100 tests
    EUR 379.2
    Description: Mouse monoclonal CD1a antibody (FITC)

    CD1a(O10) Antibody

    BNC040667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF405S conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC040667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF405S conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC041034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF405S conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC041034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF405S conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC050667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF405M conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC050667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF405M conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCAP0667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCAP0667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCAP1034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCAP1034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCB0667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), Biotin conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCB0667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), Biotin conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCB1034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), Biotin conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCB1034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), Biotin conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCP0667-250 250uL
    EUR 459.6
    Description: Primary antibody against CD1a(O10), PerCP conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCP1034-250 250uL
    EUR 459.6
    Description: Primary antibody against CD1a(66IIC7), PerCP conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCR0667-250 250uL
    EUR 459.6
    Description: Primary antibody against CD1a(O10), RPE conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCR1034-250 250uL
    EUR 459.6
    Description: Primary antibody against CD1a(66IIC7), RPE conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC940667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF594 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC940667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF594 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC941034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF594 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC941034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF594 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCA0667-250 250uL
    EUR 459.6
    Description: Primary antibody against CD1a(O10), APC conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCA1034-250 250uL
    EUR 459.6
    Description: Primary antibody against CD1a(66IIC7), APC conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC810667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF680R conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC810667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF680R conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC811034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF680R conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC811034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF680R conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNUB0667-100 100uL
    EUR 250.8
    Description: Primary antibody against CD1a(O10), Concentration: 0.2mg/mL

    CD1a(O10) Antibody

    BNUB0667-500 500uL
    EUR 549.6
    Description: Primary antibody against CD1a(O10), Concentration: 0.2mg/mL

    CD1a(66IIC7) Antibody

    BNUB1034-100 100uL
    EUR 250.8
    Description: Primary antibody against CD1a(66IIC7), Concentration: 0.2mg/mL

    CD1a(66IIC7) Antibody

    BNUB1034-500 500uL
    EUR 549.6
    Description: Primary antibody against CD1a(66IIC7), Concentration: 0.2mg/mL

    CD1a(O10) Antibody

    BNCH0667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNCH0667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCH1034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNCH1034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC880667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF488A conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC880667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF488A conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC881034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF488A conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC881034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF488A conjugate, Concentration: 0.1mg/mL

    CD1a Conjugated Antibody

    C49610 100ul
    EUR 476.4

    CD1a(O10) Antibody

    BNC680667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF568 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC680667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF568 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC681034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF568 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC681034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF568 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC470667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF647 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC470667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF647 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC471034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF647 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC471034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF647 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC400667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF640R conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC400667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF640R conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC401034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF640R conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC401034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF640R conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC430667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF543 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC430667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF543 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC431034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF543 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC431034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF543 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC550667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF555 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC550667-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(O10), CF555 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC551034-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(66IIC7), CF555 conjugate, Concentration: 0.1mg/mL

    CD1a(66IIC7) Antibody

    BNC551034-500 500uL
    EUR 652.8
    Description: Primary antibody against CD1a(66IIC7), CF555 conjugate, Concentration: 0.1mg/mL

    CD1a(O10) Antibody

    BNC610667-100 100uL
    EUR 238.8
    Description: Primary antibody against CD1a(O10), CF660R conjugate, Concentration: 0.1mg/mL

    CD1A/B Rabbit Polyclonal Antibody

    Scroll to Top